Хірургічне втручання у пацієнтів, які проходять антитромбоцитарну терапію 6 страница

380. Chawla LS, Zhao Y, Lough FC, Schroeder E, Seneff MG, Brennan JM. Off-pump vs on-pump coronary artery bypass grafting outcomes stratified by preoperative renal­function. J Am Soc Nephrol 2012;23(8):1389–1397

381. Charytan DM, Yang SS, McGurk S, Rawn J. Long and short-term outcomes following­coronary artery bypass grafting in patients with and without chronic kidney­disease. Nephrol Dial Transplant 2010;25(11):3654–3663

382. Chang TI, Shilane D, Kazi DS, Montez-Rath ME, Hlatky MA,WinkelmayerWC.Multivessel­coronary artery bypass grafting vs. percutaneous coronary intervention in­ESRD. J Am Soc Nephrol 2012;23(12):2042–2049

383. Herzog CA, Ma JZ, Collins AJ. Long-term outcome of renal transplant recipients in­the United States after coronary revascularization procedures. Circulation 2004;­109(23):2866–2871

384. Brar SS, Shen AY, Jorgensen MB, Kotlewski A, Aharonian VJ, Desai N, Ree M,­Shah AI, Burchette RJ. Sodium bicarbonate vs.sodium chloride for the prevention­of contrast medium-induced nephropathy in patients undergoing coronary angiography:­a randomized trial. JAMA 2008;300(9):1038–1046

385. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ,­Bersin RM, Van Moore A, Simonton CA 3rd, Rittase RA, Norton HJ,­Kennedy TP. Prevention of contrast-induced nephropathy with sodium bicarbonate:­a randomized controlled trial. JAMA 2004;291(19):2328–2334

386. Li Y, Liu Y, Fu L, Mei C, Dai B. Efficacy of short-term high-dose statin in preventing­contrast-induced nephropathy: a meta-analysis of seven randomized controlled­trials. PLoS One 2012;7(4):e34450

387. Sadat U, Usman A, Gillard JH, Boyle JR. Does ascorbic acid protect against­contrast-induced acute kidney injury in patients undergoing coronary angiography:­a systematic review with meta-analysis of randomized, controlled trials. J Am Coll­Cardiol 2013;62(23):2167–2175

388. Marenzi G, Assanelli E, Campodonico J, Lauri G, Marana I,DeMetrio M,Moltrasio M,­Grazi M, Rubino M, Veglia F, Fabbiocchi F, Bartorelli AL. Contrast volume during­primary percutaneous coronary intervention and subsequent contrast-induced­nephropathy and mortality. Ann Intern Med 2009;150(3):170–177

389. Laskey WK, Jenkins C, Selzer F, Marroquin OC, Wilensky RL, Glaser R, Cohen HA,­Holmes DR Jr. Volume-to-creatinine clearance ratio: a pharmacokinetically based­risk factor for prediction of early creatinine increase after percutaneous coronary­intervention. J Am Coll Cardiol 2007;50(7):584–590

390. Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Cannon CP, Saucedo JF,­Kontos MC, Wiviott SD. Use of evidence-based therapies in short-term outcomes­of ST-segment elevation myocardial infarction and non-ST-segment elevation­myocardial infarction in patients with chronic kidney disease: a report from the National­Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes­Network registry. Circulation 2010;121(3):357–365

391. Yan LQ, Guo LJ, Zhang FC, GaoW. The relationship between kidney function and­angiographically-derived SYNTAX score. Can J Cardiol 2011;27(6):768–772

392. Zheng H, Xue S, Lian F, Huang RT,HuZL,Wang YY. Meta-analysis of clinical studies­comparing coronary artery bypass grafting with percutaneous coronary intervention­in patients with end-stage renal disease. Eur J Cardiothorac Surg 2013;43(3):­459–467

393. Del Duca D, Iqbal S, Rahme E, Goldberg P, de Varennes B. Renal failure after cardiac­surgery: timing of cardiac catheterization and other perioperative risk factors. Ann­Thorac Surg 2007;84(4):1264–1271

394. Ranucci M, Ballotta A, Kunkl A, De Benedetti D, Kandil H, Conti D, Mollichelli N,­Bossone E, Mehta RH. Influence of the timing of cardiac catheterization and the­amount of contrast media on acute renal failure after cardiac surgery. Am J­Cardiol 2008;101(8):1112–1118

395. Medalion B, Cohen H, Assali A, Vaknin Assa H, Farkash A, Snir E, Sharoni E,­Biderman P, Milo G, Battler A, Kornowski R, Porat E. The effect of cardiac angiography­timing, contrast media dose, and preoperative renal function on acute renal­failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg;139(6):­1539–1544

396. Sajja LR, Mannam G, Chakravarthi RM, Sompalli S, Naidu SK, Somaraju B,­Penumatsa RR. Coronary artery bypass grafting with or without cardiopulmonary­bypass in patients with preoperative non-dialysis dependent renal insufficiency: a­randomized study. J Thorac Cardiovasc Surg 2007;133(2):378–388

397. Maioli M, Toso A, Leoncini M, Micheletti C, Bellandi F. Effects of hydration in­contrast-induced acute kidney injury after primary angioplasty: a randomized, controlled­trial. Circ Cardiovasc Interv 2011;4(5):456–462

398. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic­effects in high-risk patients undergoing angiography. N Engl J Med 2003;348(6):­491–499

399. Jo SH, Youn TJ, Koo BK, Park JS, Kang HJ, Cho YS, Chung WY, Joo GW, Chae IH,­Choi DJ, Oh BH, Lee MM, Park YB, Kim HS. Renal toxicity evaluation and comparison­between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal­insufficiency undergoing coronary angiography: the RECOVER study: a randomized­controlled trial. J Am Coll Cardiol 2006;48(5):924–930

400. Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE,­Gelormini JL, Labinaz M, Moreyra AE. Cardiac Angiography in Renally Impaired­Patients (CARE) study: a randomized double-blind trial of contrast-induced­nephropathy in patients with chronic kidney disease. Circulation 2007;115(25):­3189–3196

401. Leoncini M, Toso A, Maioli M, Tropeano F, Villani S, Bellandi F. Early high-dose rosuvastatin­for Contrast-Induced Nephropathy Prevention in Acute Coronary Syndrome Results from Protective effect of Rosuvastatin and Antiplatelet Therapy­On contrast-induced acute kidney injury and myocardial damage in patients with­Acute Coronary Syndrome (PRATO-ACS Study). J Am Coll Cardiol 2014;63(1):­71–79

402. McCullough PA, Bertrand ME, Brinker JA, Stacul F. A meta-analysis of the renal­safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am­Coll Cardiol 2006;48(4):692–699

403. Briguori C, Visconti G, Focaccio A, Airoldi F, Valgimigli M, Sangiorgi GM, Golia B,­Ricciardelli B, Condorelli G. Renal Insufficiency After Contrast Media Administration­Trial II (REMEDIAL II): RenalGuard System in high-risk patients for­contrast-induced acute kidney injury. Circulation 2011;124(11):1260–1269

404. Marenzi G, Ferrari C, Marana I, Assanelli E, De Metrio M, Teruzzi G, Veglia F,­Fabbiocchi F, Montorsi P, Bartorelli AL. Prevention of contrast nephropathy by furosemide­with matched hydration: the MYTHOS (Induced Diuresis With Matched­Hydration Compared to Standard Hydration for Contrast Induced Nephropathy­Prevention) trial. JACC Cardiovasc Interv 2012;5(1):90–97

405. ACT-Investigators. Acetylcysteine for prevention of renal outcomes in patients­undergoing coronary and peripheral vascular angiography: main results from the­randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation­2011;124(11):1250–1259

406. Klima T, Christ A, Marana I, Kalbermatter S, Uthoff H, Burri E, Hartwiger S,­Schindler C, Breidthardt T, Marenzi G, Mueller C. Sodium chloride vs. sodium bicarbonate­for the prevention of contrast medium-induced nephropathy: a randomized­controlled trial. Eur Heart J 2012;33(16):2071–2079

407. Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, Trabattoni D,­Fabbiocchi F, Montorsi P, Bartorelli AL. The prevention of radiocontrastagent-­induced nephropathy by hemofiltration. N Engl J Med 2003;349(14):­1333–1340

408. Marenzi G, Lauri G, Campodonico J, Marana I, Assanelli E, De Metrio M, Grazi M,­Veglia F, Fabbiocchi F, Montorsi P, Bartorelli AL. Comparison of two hemofiltration­protocols for prevention of contrast-induced nephropathy in high-risk patients.Am­J Med 2006;119(2):155–162

409. Cruz DN, Goh CY, Marenzi G, Corradi V, Ronco C, Perazella MA. Renal replacement­therapies for prevention of radiocontrast-induced nephropathy: a systematic­review. Am J Med 2012;125(1):p66–78, e3

410. Vogt B, Ferrari P, Schonholzer C, Marti HP, Mohaupt M, Wiederkehr M,­Cereghetti C, Serra A, Huynh-Do U, Uehlinger D, Frey FJ. Prophylactic hemodialysis­after radiocontrast media in patients with renal insufficiency is potentially­harmful. Am J Med 2001;111(9):692–698

411. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H,­Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P,­Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J,­Von Oppell UO, Windecker S, Zamorano JL, Zembala M. Guidelines on the management­of valvular heart disease (version 2012). Eur Heart J 2012;33(19):­2451–2496

412. Czer LS, Gray RJ, Stewart ME, De Robertis M, Chaux A, Matloff JM. Reduction in­sudden late death by concomitant revascularization with aortic valve replacement J Thorac Cardiovasc Surg 1988;95(3):390–401

413. Iung B, Drissi MF, Michel PL, de Pamphilis O, Tsezana R, Cormier B, Vahanian A,­Acar J. Prognosis of valve replacement for aortic stenosis with or without coexisting­coronary heart disease: a comparative study. J Heart Valve Dis 1993;2(4):430–439

414. Lund O, Nielsen TT, Pilegaard HK, Magnussen K, Knudsen MA. The influence of­coronary artery disease and bypass grafting on early and late survival after valve replacement­for aortic stenosis. J Thorac Cardiovasc Surg 1990;100(3):327–337

415. Mullany CJ, Elveback LR, Frye RL, Pluth JR, Edwards WD, Orszulak TA, Nassef LA­Jr., Riner RE, Danielson GK. Coronary artery disease and its management: influence­on survival in patients undergoing aortic valve replacement. J Am Coll Cardiol 1987;­10(1):66–72

416. Hannan EL, Wu C, Bennett EV, Carlson RE, Culliford AT, Gold JP, Higgins RS,­Smith CR, Jones RH. Risk index for predicting in-hospital mortality for cardiac­valve surgery. Ann Thorac Surg 2007;83(3):921–929

417. van Gameren M, Kappetein AP, Steyerberg EW, Venema AC, Berenschot EA,­Hannan EL, Bogers AJ, Takkenberg JJ. Do we need separate risk stratification­models for hospital mortality after heart valve surgery? Ann Thorac Surg 2008;­85(3):921–930

418. Hamm CW, Mollmann H, Holzhey D, Beckmann A, Veit C, Figulla HR, Cremer J,­Kuck KH, Lange R, Zahn R, Sack S, Schuler G,Walther T, Beyersdorf F, Bohm M,­Heusch G, Funkat AK, Meinertz T, Neumann T, Papoutsis K, Schneider S,­Welz A, Mohr FW. The German Aortic Valve Registry (GARY): in-hospital­outcome. Eur Heart J 2014;35:1588–1598

419. Beach JM, MihaljevicT, SvenssonLG, Rajeswaran J,Marwick T, GriffinB, Johnston DR,­Sabik JF 3rd, Blackstone EH. Coronary artery disease outcomes of aortic valve replacement­for severe aortic stenosis. J AmColl Cardiol 2013;61(8):837–848

420. D’Ascenzo F, Conrotto F, Giordana F, Moretti C, D’Amico M, Salizzoni S, OmedeP,­La Torre M, Thomas M, Khawaja Z, Hildick-Smith D, Ussia G, Barbanti M,­Tamburino C, Webb J, Schnabel RB, Seiffert M, Wilde S, Treede H,­Gasparetto V, Napodano M, Tarantini G, Presbitero P, Mennuni M, Rossi ML,­Gasparini M, Biondi Zoccai G, Lupo M, Rinaldi M, Gaita F, Marra S. Mid-term prognostic­value of coronary artery disease in patients undergoing transcatheter aortic­valve implantation: A meta-analysis of adjusted observational results. Int J Cardiol­2013;168(3):2528–2532

421. Stefanini GG, Stortecky S, Cao D et al. Coronary artery disease severity and aortic­stenosis: clinical outcomes according to SYNTAX-score in patients undergoing­transcatheter aortic valve implantation. Eur Heart J 2014. Published online 28­March 2014; doi:1093/eurheartj/ehu074

422. Wenaweser P, Pilgrim T, Guerios E, Stortecky S, Huber C, Khattab AA, Kadner A,­Buellesfeld L, Gloekler S, Meier B, CarrelT, Windecker S. Impact of coronary artery­disease and percutaneous coronary intervention on outcomes in patients with­severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention­2011;7(5):541–548

423. Abdel-Wahab M, Mostafa AE, Geist V, Stocker B, Gordian K, Merten C, Richardt D,­Toelg R, Richardt G. Comparison of outcomes in patients having isolated transcatheter­aortic valve implantation vs. combined with preprocedural percutaneous coronary­intervention. Am J Cardiol 2012;109(4):581–586

424. Conradi L, Seiffert M, Franzen O, Baldus S, Schirmer J, Meinertz T,­Reichenspurner H, Treede H. First experience with transcatheter aortic valve implantation­and concomitant percutaneous coronary intervention. Clin Res Cardiol­2011;100(4):311–316

425. Van Mieghem NM, van der Boon RM, Faqiri E, Diletti R, Schultz C, van Geuns RJ,­SerruysPW, Kappetein AP, van Domburg RT, de Jaegere PP. Complete revascularization­is not a prerequisite for success in current transcatheter aortic valve implantation­practice. JACC Cardiovasc Interv 2013;6(8):867–875

426. Gautier M, Pepin M, Himbert D, Ducrocq G, Iung B, Dilly MP, Attias D, Nataf P,­Vahanian A. Impact of coronary artery disease on indications for transcatheter­aortic valve implantation and on procedural outcomes. EuroIntervention 2011;­7(5):549–555

427. Pasic M, Unbehaun A, DrewsT, Hetzer R. Latewound healing problems after use of­BioGlue for apical hemostasis during transapical aortic valve implantation. Interact­Cardiovasc Thorac Surg 2011;13(5):532–534

428. Pasic M, Dreysse S, Unbehaun A, Buz S, Drews T, Klein C, D’Ancona G, Hetzer R Combined elective percutaneous coronary intervention and transapical transcatheter­aortic valve implantation. Interact Cardiovasc Thorac Surg 2012;14(4):463–468

429. Goel SS, Ige M, Tuzcu EM, Ellis SG, Stewart WJ, Svensson LG, LytleBW, Kapadia SR Severe aortic stenosis and coronary artery disease:implications for management in­the transcatheter aortic valve replacement era: a comprehensive review. J Am Coll­Cardiol 2013;62(1):1–10

430. Byrne JG, Leacche M, Vaughan DE, Zhao DX. Hybrid cardiovascular procedures JACC Cardiovasc Interv 2008;1(5):459–468

431. Deja MA, Grayburn PA, Sun B, Rao V, She L, Krejca M, Jain AR, Leng Chua Y, Daly R,­Senni M, Mokrzycki K, Menicanti L, Oh JK, Michler R, Wrobel K, Lamy A,­Velazquez EJ, Lee KL, Jones RH. Influence of mitral regurgitation repair on survival­in the surgical treatment for ischemic heart failure trial. Circulation 2012;125(21):­2639–2648

432. Chan KM, Punjabi PP, Flather M,Wage R, Symmonds K, Roussin I, Rahman-Haley S,­Pennell DJ, Kilner PJ, Dreyfus GD, Pepper JR, Investigators R. Coronary artery­bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic­mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation­(RIME) trial. Circulation 2012;126(21):2502–2510

433. Aboyans V, Lacroix P. Indications for carotid screening in patients with coronary­artery disease. Presse Med 2009;38(6):977–986

434. Chaturvedi S, Bruno A, Feasby T, Holloway R, Benavente O, Cohen SN, Cote R,­Hess D, Saver J, Spence JD, Stern B, Wilterdink J. Carotid endarterectomy:an­evidence-based review: report of the Therapeutics and Technology Assessment­Subcommittee of the American Academy of Neurology. Neurology 2005;65(6):­794–801

435. LiY,Walicki D, Mathiesen C, Jenny D, Li Q, IsayevY, Reed JF 3rd, Castaldo JE. Strokes­after cardiac surgery and relationship to carotid stenosis. Arch Neurol 2009;66(9):­1091–1096

436. Tarakji KG, Sabik JF 3rd, Bhudia SK, Batizy LH, Blackstone EH. Temporal onset, risk­factors, and outcomes associated with stroke after coronary artery bypass grafting JAMA 2011;305(4):381–390

437. Ratib K, Mamas MA, Routledge HC, Ludman PF, Fraser D, Nolan J. Influence of­access site choice on incidence of neurologic complications after percutaneous­coronary intervention. Am Heart J 2013;165(3):317–324

438. Wardlaw JM, Chappell FM, Stevenson M, De Nigris E, Thomas S, Gillard J, Berry E,­Young G, Rothwell P, Roditi G, Gough M, Brennan A, Bamford J, Best J. Accurate,­practical and cost-effective assessment of carotid stenosis in the UK. Health­Technol Assess 2006;10(30):iii–iv, ix–x, 1–182

439. Zingone B, Rauber E, Gatti G, Pappalardo A, Benussi B, Dreas L, Lattuada L. The­impact of epiaortic ultrasonographic scanning on the risk of perioperative stroke Eur J Cardiothorac Surg 2006;29(5):720–728

440. Marui A, Okabayashi H, KomiyaT, Tanaka S, Furukawa Y, Kita T, KimuraT, Sakata R Benefits of off-pump coronary artery bypass grafting in high-risk patients. Circulation­2012;126(11 Suppl 1):S151–157

441. Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Paolasso E, Straka Z,­Piegas LS, Akar AR, Jain AR, Noiseux N, Padmanabhan C, Bahamondes JC,­Novick RJ, Vaijyanath P, Reddy S, Tao L, Olavegogeascoechea PA, Airan B,­Sulling TA, Whitlock RP, Ou Y, Ng J, Chrolavicius S, Yusuf S. Off-pump or­on-pump coronary-artery bypass grafting at 30 days. N Engl J Med 2012;366(16):­1489–1497

442. Emmert MY, Seifert B, Wilhelm M, Grunenfelder J, Falk V, Salzberg SP. Aortic­no-touch technique makes the difference in off-pump coronary artery bypass grafting J Thorac Cardiovasc Surg 2011;142(6):1499–1506

443. Misfeld M, Brereton RJ, Sweetman EA, Doig GS. Neurologic complications after­off-pump coronary artery bypass grafting with and without aortic manipulation:­meta-analysis of 11,398 cases from 8 studies. J Thorac Cardiovasc Surg 2011;­142(2):e11–e17

444. Bouchard D, Carrier M, Demers P, Cartier R, Pellerin M, Perrault LP, Lambert J Statin in combination with beta-blocker therapy reduces postoperative stroke­after coronary artery bypass graft surgery. Ann Thorac Surg 2011;91(3):654–659

445. Ederle J, Featherstone RL, Brown MM. Randomized controlled trials comparing­endarterectomy and endovascular treatment for carotid artery stenosis: a­Cochrane systematic review. Stroke 2009;40(4):1373–1380

446. Ederle J, Dobson J, Featherstone RL, Bonati LH, van der Worp HB, de Borst GJ,­Lo TH, Gaines P, Dorman PJ, Macdonald S, Lyrer PA, Hendriks JM, McCollum C,­Nederkoorn PJ, Brown MM. Carotid artery stenting compared with endarterectomy­in patients with symptomatic carotid stenosis (International Carotid Stenting­Study): an interim analysis of a randomised controlled trial. Lancet 2010;375(9719):­985–997

447. Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W,­Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH,­Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN,­Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF. Stenting vs. endarterectomy­for treatment of carotid-artery stenosis. N Engl J Med 2010;363(1):11–23

448. Bonati LH, Lyrer P, Ederle J, Featherstone R, BrownMM.Percutaneous transluminal­balloon angioplasty and stenting for carotid artery stenosis. Cochrane Database Syst­Rev 2012;9:CD000515

449. Shishehbor MH, Venkatachalam S, Sun Z, Rajeswaran J, Kapadia SR, Bajzer C,­Gornik HL, Gray BH, Bartholomew JR, Clair DG, Sabik JF 3rd, Blackstone EH. A­Direct Comparison of Early and Late Outcomes with Three Approaches to­Carotid Revascularization and Open Heart Surgery. J Am Coll Cardiol 2013;­62(21):1948–1956

450. Nallamothu BK, Gurm HS, Ting HH, Goodney PP, Rogers MA, Curtis JP, Dimick JB,­Bates ER, Krumholz HM, Birkmeyer JD. Operator experience and carotid stenting­outcomes in Medicare beneficiaries. JAMA 2011;306(12):1338–1343

451. Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, Collet JP,­Cremonesi A, De Carlo M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E,­Ostergren J, Poldermans D, Riambau V, Roffi M, Rother J, Sievert H, van­Sambeek M, Zeller T. ESC Guidelines on the diagnosis and treatment of peripheral­artery diseases: Document covering atherosclerotic disease of extracranial carotid­and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task­Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European­Society of Cardiology (ESC). Eur Heart J 2011;32(22):2851–2906

452. Ziada KM, Yadav JS, Mukherjee D, Lauer MS, Bhatt DL, Kapadia S, Roffi M, Vora N,­Tiong I, Bajzer C. Comparison of results of carotid stenting followed by open heart­surgery vs. combined carotid endarterectomy and open heart surgery (coronary­bypass with or without another procedure). Am J Cardiol 2005;96(4):519–523

453. Don CW, House J, White C, Kiernan T, Weideman M, Ruggiero N, McCann A,­Rosenfield K. Carotid revascularization immediately before urgent cardiac­surgery practice patterns associated with the choice of carotid artery stenting or­endarterectomy: a report from the CARE (Carotid Artery Revascularization and­Endarterectomy) registry. JACC Cardiovasc Interv 2011;4(11):1200–1208

454. Antithrombotic Trialists C. Collaborative meta-analysis of randomised trials of­antiplatelet therapy for prevention of death, myocardial infarction, and stroke in­high risk patients. BMJ 2002;324(7329):71–86

455. Dalainas I, Nano G, Bianchi P, Stegher S, Malacrida G, Tealdi DG. Dual antiplatelet­regime vs. acetyl-acetic acid for carotid artery stenting. Cardiovasc Intervent Radiol­2006;29(4):519–521

456. McKevitt FM, Randall MS, Cleveland TJ, Gaines PA, Tan KT, Venables GS. The benefits­of combined anti-platelet treatment in carotid artery stenting. Eur J Vasc Endovasc­Surg 2005;29(5):522–527

457. Parikh SV, Saya S, Divanji P, Banerjee S, Selzer F, Abbott JD, Naidu SS, Wilensky RL,­FaxonDP, Jacobs AK, Holper EM. Risk of death and myocardial infarction in patients­with peripheral arterial disease undergoing percutaneous coronary intervention­(from the National Heart, Lung and Blood Institute Dynamic Registry). Am J­Cardiol 2011;107(7):959–964

458. Brilakis ES, Hernandez AF, Dai D, Peterson ED, Banerjee S, Fonarow GC,­Cannon CP, Bhatt DL. Quality of care for acute coronary syndrome patients­with known atherosclerotic disease: results from the Get With the Guidelines­Program. Circulation 2009;120(7):560–567

459. Diehm N, Schmidli J, Setacci C, Ricco JB, de Donato G, Becker F, Robert-Ebadi H,­Cao P, Eckstein HH, De Rango P, Teraa M, Moll FL, Dick F, Davies AH, Lepantalo M,­Apelqvist J. Chapter III: Management of cardiovascular risk factors and medical­therapy. Eur J Vasc Endovasc Surg 2011;42 Suppl 2:S33–42

460. McFalls EO,Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, Pierpont G,­Santilli S, Rapp J, Hattler B, Shunk K, Jaenicke C, Thottapurathu L, Ellis N, Reda DJ,­HendersonWG.Coronary-artery revascularization before electivemajor vascular­surgery. N Engl J Med 2004;351(27):2795–2804

461. Monaco M, Stassano P, Di Tommaso L, Pepino P, Giordano A, Pinna GB, Iannelli G,­Ambrosio G. Systematic strategy of prophylactic coronary angiography improves­long-term outcome after major vascular surgery in medium- to high-risk patients:­a prospective, randomized study. J Am Coll Cardiol 2009;54(11):989–996

462. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE,­Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF. 2009­ACCF/AHA focused update on perioperative beta blockade incorporated into­the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and­care for noncardiac surgery: a report of the American college of cardiology­foundation/American heart association task force on practice guidelines. Circulation­2009;120(21):e169–e276

463. Zhao DX, Leacche M, Balaguer JM, Boudoulas KD, Damp JA, Greelish JP, Byrne JG,­WritingGroup of the Cardiac Surgery CA,Interventional Cardiology Groupsat the­Vanderbilt H, Vascular I, Ahmad RM, Ball SK, Cleator JH, Deegan RJ, Eagle SS,­Fong PP, Fredi JL, Hoff SJ, Jennings HS 3rd, McPherson JA, Piana RN, Pretorius M,­Robbins MA, Slosky DA, Thompson A. Routine intraoperative completion angiography­after coronary artery bypass grafting and 1-stop hybrid revascularization­results from a fully integrated hybrid catheterization laboratory/operating room J Am Coll Cardiol 2009;53(3):232–241

464. Thielmann M, Massoudy P, Jaeger BR, Neuhauser M, Marggraf G, Sack S, Erbel R,­Jakob H. Emergency re-revascularization with percutaneous coronary intervention,­reoperation, or conservative treatment in patients with acute perioperative­graft failure following coronary artery bypass surgery. Eur J Cardiothorac Surg­2006;30(1):117–125

465. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Writing­Group on the Joint ESCAAHAWHFTFftUDoMI, Thygesen K, Alpert JS,­White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BA,­Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F,­Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF,­Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J, Ohman EM, Antman EM,­Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS,­Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD,­Levy D,Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM,Weaver D,­Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S,­Guidelines ESCCfP. Third universal definition of myocardial infarction. Eur Heart­J 2012;33(20):2551–2567

466. Davierwala PM, Verevkin A, Leontyev S, Misfeld M, BorgerMA,MohrFW. Impact of­expeditious management of perioperative myocardial ischemia in patients undergoing­isolated coronary artery bypass surgery. Circulation 2013;128(11 Suppl 1):­S226–234

467. Laflamme M, DeMey N, Bouchard D, Carrier M, Demers P, Pellerin M, Couture P,­Perrault LP. Management of early postoperative coronary artery bypass graft­failure. Interact Cardiovasc Thorac Surg 2012;14(4):452–456

468. Subramanian S, Sabik JF 3rd, Houghtaling PL, Nowicki ER, Blackstone EH, LytleBW Decision-making for patients with patent left internal thoracic artery grafts to left­anterior descending. Ann Thorac Surg 2009;87(5):1392–1398; discussion 1400

469. Desai ND, Cohen EA, Naylor CD, Fremes SE, Radial Artery Patency Study I.A randomized­comparison of radial-artery and saphenous-vein coronary bypass grafts.N­Engl J Med 2004;351(22):2302–2309

470. Deb S, Cohen EA, Singh SK, Une D, Laupacis A, Fremes SE, Investigators R. Radial­artery and saphenous vein patency more than 5 years after coronary artery bypass­surgery: results from RAPS (Radial Artery Patency Study). J Am Coll Cardiol 2012;­60(1):28–35

471. Tatoulis J, Buxton BF, Fuller JA. Patencies of 2127 arterial to coronary conduits over­15 years. Ann Thorac Surg 2004;77(1):93–101

472. Hattler B, Messenger JC, Shroyer AL, Collins JF, Haugen SJ, Garcia JA, Baltz JH,­Cleveland JC Jr., Novitzky D, Grover FL. Off-Pump coronary artery bypass­surgery is associated with worse arterial and saphenous vein graft patency and­less effective revascularization: Results from the Veterans Affairs Randomized­On/Off Bypass (ROOBY) trial. Circulation 2012;125(23):2827–2835

473. Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB Jr., Lorenz TJ,­Goyal A, Gibson M, Mack MJ, Gennevois D, CaliffRM, KouchoukosNT. Efficacy and­safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft­failure following coronary artery bypass graft surgery: PREVENT IV: a randomized­controlled trial. JAMA 2005;294(19):2446–2454

474. Tatoulis J, Buxton BF, Fuller JA. The right internal thoracic artery: the forgotten­conduit:5,766 patients and 991 angiograms. Ann Thorac Surg 2011;92(1):9–15; discussion­15–17

475. Barner HB, Bailey M, Guthrie TJ, Pasque MK, Moon MR, Damiano RJ Jr., Lawton JS Radial artery free and T graft patency as coronary artery bypass conduit over a­15-year period. Circulation 2012;126(11 Suppl 1):S140–144

476. Achouh P, Boutekadjirt R, Toledano D, Hammoudi N, Pagny JY, Goube P,­Isselmou KO, Lancelin B, Fouquet R, Acar C. Long-term (5- to 20-year) patency­of the radial artery for coronary bypass grafting. J Thorac Cardiovasc Surg 2010;­140(1):73–79, 79 e1–e2

477. Sabik JF 3rd, Blackstone EH, Houghtaling PL,Walts PA, LytleBW. Is reoperation still­a risk factor in coronary artery bypass surgery? Ann Thorac Surg 2005;80(5):­1719–1727

478. Yap CH, Sposato L, Akowuah E, Theodore S, DinhDT, Shardey GC, Skillington PD,­Tatoulis J, Yii M, Smith JA, Mohajeri M, Pick A, Seevanayagam S, Reid CM. Contemporary­results show repeat coronary artery bypass grafting remains a risk factor for­operative mortality. Ann Thorac Surg 2009;87(5):1386–1391

479. Morrison DA, Sethi G, Sacks J, Henderson WG, Grover F, Sedlis S, Esposito R,­Investigators of the Department of Veterans Affairs Cooperative Study­AWESOME. Percutaneous coronary intervention vs. repeat bypass surgery for­patients with medically refractory myocardial ischemia: AWESOME randomized­trial and registry experience with post-CABG patients. J Am Coll Cardiol 2002;­40(11):1951–1954

480. Harskamp RE, BeijkMA, Damman P, Kuijt WJ,Woudstra P, Grundeken MJ, Kloek JJ,­Tijssen JG, de Mol BA, de Winter RJ. Clinical outcome after surgical or percutaneous­revascularization in coronary bypass graft failure. J Cardiovasc Med (Hagerstown)­2013;14(6):438–445

481. Sabik JF 3rd, Raza S, Blackstone EH, Houghtaling PL, Lytle BW. Value of internal­thoracic artery grafting to the left anterior descending coronary artery at coronary­reoperation. J Am Coll Cardiol 2013;61(3):302–310

482. Coolong A, Baim DS, Kuntz RE, O’Malley AJ, Marulkar S, Cutlip DE, Popma JJ,­Mauri L. Saphenous vein graft stenting and major adverse cardiac events: a predictive­model derived from a pooled analysis of 3958 patients. Circulation 2008;117(6):­790–797

Не нашли, что искали? Воспользуйтесь поиском: